Absci Corp (ABSI)
4.21
-0.04
(-0.94%)
USD |
NASDAQ |
May 31, 16:00
4.19
-0.02
(-0.48%)
Pre-Market: 20:00
Absci Free Cash Flow: -62.38M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -62.38M |
| December 31, 2023 | -65.50M |
| September 30, 2023 | -69.68M |
| June 30, 2023 | -82.93M |
| March 31, 2023 | -89.91M |
| December 31, 2022 | -97.51M |
| September 30, 2022 | -103.78M |
| Date | Value |
|---|---|
| June 30, 2022 | -107.24M |
| March 31, 2022 | -113.00M |
| December 31, 2021 | -98.64M |
| September 30, 2021 | -76.69M |
| June 30, 2021 | -52.77M |
| March 31, 2021 | -24.18M |
| December 31, 2020 | -13.15M |
Free Cash Flow Range, Past 5 Years
-113.00M
Minimum
Mar 2022
-13.15M
Maximum
Dec 2020
-75.53M
Average
-79.81M
Median
Free Cash Flow Benchmarks
| Eli Lilly and Co | -3.896B |
| Creative Medical Technology Holdings Inc | -5.083M |
| CytomX Therapeutics Inc | -92.34M |
| Bristol-Myers Squibb Co | 12.51B |
| Recursion Pharmaceuticals Inc | -330.63M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -17.86M |
| Cash from Investing (Quarterly) | -76.68M |
| Cash from Financing (Quarterly) | 81.18M |
| Free Cash Flow Per Share (Quarterly) | -0.1797 |
| Free Cash Flow to Equity (Quarterly) | -16.99M |
| Free Cash Flow to Firm (Quarterly) | -17.69M |
| Free Cash Flow Yield | -15.76% |